OPHLF:OTCMKTS
Ono Pharmaceutical Co Ltd
$14.61
0.00%
(0.00) 1D
Jul 27, 12:17:58 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OPHLF...
Mkt. cap
1.17T
Avg. vol.
192.00
Volume
0.00
52-wk high
$18.67
52-wk low
$10.27
Beta
-6.33
Shares outstanding
498.69M
No. of employees
4K
Mkt. cap
1.17T
Avg. vol.
192.00
Volume
0.00
52-wk high
$18.67
52-wk low
$10.27
Beta
-6.33
Shares outstanding
498.69M
No. of employees
4K
News stories
From sources across the web
finance.biggo.com
·
7 hours ago
【Ono Pharmaceutical FY2026 Q1 Earnings Call】Core Operating Profit Up 22.5% to ¥38.7 Billion; Overseas Sales and Royalties Drive Post-Forxiga Revenue Structure, Upside Potential from Weak Yen
Yahoo Finance
·
2 days ago
Ono Pharmaceutical Co. (OPHLF) Q1 Earnings and Revenues Top Estimates
Profile
Ono Pharmaceutical Co., Ltd. is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in Higashinari-ku, Osaka, and Fujinomiya, Shizuoka., and its central research institute at Minase, Shimamoto-cho, Mishima District, Osaka.
Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. in 1948.
Ono has been listed in Tokyo Stock Exchange since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen.
Nivolumab, the cancer drug based on the research of Prof. Dr. Tasuku Honjo of Kyoto University, who received the Nobel Prize later in 2018, is marketed by both Ono Pharmaceutical and Bristol-Myers Squibb.
In 2024, Harvard University and Ono Pharmaceutical entered into a joint research and drug development agreement. Under it, promising projects to test therapeutic targets will be selected over 5 years under the guidance of Harvard's Office of Technology Development, and ONO will fund the work. Wikipedia
About Ono Pharmaceutical Co Ltd
CEOGyo Sagara | Gyo Sagara
Employees4.21K
Founded1717
HeadquartersOsaka, Osaka, Japan
SectorPharmaceutical industry
Websiteono-pharma.com
AI content may include mistakes. Learn more